undefined undefined
NaN.000
NaN.00%
Throughout the last three months, 8 analysts have evaluated NovoCure (NASDAQ:NV...
05-03 05:01
Analysts have been eager to weigh in on the Healthcare sector with new ratings ...
05-03 00:30
Novocure (NASDAQ:NVCR) Thursday said that it has entered into a new five-year up to $400 million committed senior secured credit facility with funds managed by Pharmakon Advisors, LP. NVCR shares up +...
05-02 19:51
Use of proceeds to fund working capital needs stemming from Novocure's anticipated launch in non-small cell lung cancer and settle, upon maturity, Novocure's convertible notes
05-02 19:18
NovoCure (NASDAQ:NVCR) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.42) by 14.29 percent. The company reported quarterly sales of $138.50 million which beat the analyst
05-02 19:04
Piper Sandler:重申NovoCure(NVCR.US)评级,由增持调整至增持评级, 目标价由25.00美元调整至28.00美元。
04-10 21:00
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So...
04-09 01:49
This whale alert can help traders discover the next big trading opportunities. ...
04-04 01:35
Gainers: Zapata Computing (ZPTA) +12%. Thoughtworks Holding (TWKS) +4%. Gain Therapeutics (GANX) +3%. Portillo's (PTLO) +3%. Vital Farms (VITL) +3%. Losers: Signature Bank (OTC:SBNY) -11%. Alignment ...
04-02 05:08
Zai Lab (NASDAQ:ZLAB) said a confirmatory study for Bristol Myers’ (NYSE:BMY) drug Krazati has met its primary endpoint of progression-free survival in pretreated patients with KRASG12C-mutated locall...
04-01 22:57